Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IntraBiotics,P&U codevelop and copromote oral mucositis drug

Executive Summary

Pharmacia & Upjohn and IntraBiotics are co-developing, co-promoting and will share the profits of IB-367 for the treatment of oral mucositis should it result as a marketable drug in the US. P&U will develop and promote the product outside the US.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Equity
    • R+D and Marketing-Licensing
    • Co-Promotion

Related Companies